Inotiv Partners with LifeNet Health to Leverage TruVivo System for Drug Development

Inotiv, a contract research organization, has announced a strategic initiative to leverage LifeNet Health's TruVivo system within its Discovery and Translational Sciences business. TruVivo uses primary human hepatocytes cultured with human-derived feeder cells to create physiologically relevant in vitro models, addressing a critical challenge in drug development. This technology provides a stronger foundation for predicting human responses to new therapies, connecting basic research to patient outcomes.